The Food and Drug Administration today adjusted its import screening to expedite personal protective equipment and clarified types of PPE that can be imported without engaging with FDA. To provide flexibility, FDA will facilitate access to critical legitimate PPE and devices and monitor the import systems to prevent and mitigate potential issues.

FDA established an email, COVID19FDAIMPORTINQUIRIES@fda.hhs.gov, for industry representatives to address questions or concerns. FDA also updated its FAQ on diagnostic testing for SARS-CoV-2 to answer additional questions

Related News Articles

Headline
The Federal Emergency Management Agency and Department of Health and Human Services have created a Supply Chain Stabilization Task Force to address the need…
Headline
The AHA today released a Special Bulletin with information and FAQs on the Federal Reserve emergency lending program included in the Coronavirus Aid, Relief…
Headline
Vice President Pence, on behalf of President Trump and the White House Coronavirus Task Force, Sunday sent a letter to the nation's hospitals requesting that…
Headline
The Centers for Medicare & Medicaid Services yesterday released a substantial number of new waivers related to COVID-19. The waivers apply nationwide and…
Headline
The AHA today asked the Department of Health and Human Services and Centers for Medicare & Medicaid Services to directly and expediently distribute to…
Headline
The Partnership to Amend 42 CFR Part 2, a coalition of nearly 50 health care organizations including the AHA, applauded Congress’ important step to …